Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(17%)
Results Posted
83%(5 trials)

Phase Distribution

Ph phase_3
4
33%
Ph phase_1
1
8%
Ph phase_2
3
25%
Ph phase_4
3
25%

Phase Distribution

1

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
3(27.3%)
Phase 3Large-scale testing
4(36.4%)
Phase 4Post-market surveillance
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(6)
Terminated(3)
Other(1)

Detailed Status

Completed6
Withdrawn3
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 23 (27.3%)
Phase 34 (36.4%)
Phase 43 (27.3%)

Trials by Status

completed650%
recruiting217%
withdrawn325%
unknown18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12